These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 2653503)
1. Perspectives of monoclonal antibodies in the acute leukaemias. Hervé P; Wijdenes J; Racadot E Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():198-201. PubMed ID: 2653503 [No Abstract] [Full Text] [Related]
2. Autologous bone marrow transplantation in acute leukemia and lymphoma following ex vivo treatment with monoclonal antibodies and complement. Freedman AS; Takvorian T; Nadler LM; Anderson KC; Sallan SE; Ritz J Cancer Treat Res; 1988; 38():265-83. PubMed ID: 2908599 [No Abstract] [Full Text] [Related]
3. Monoclonal antibodies and complement purged autograft in Burkitt lymphoma and lymphoblastic leukemia. Favrot M; Philip I; Combaret V; Pavone E; Bouffet E; Biron P; Philip T Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():202-4. PubMed ID: 2713555 [No Abstract] [Full Text] [Related]
4. Preliminary clinical trial of autologous bone marrow transplantation after in vitro monoclonal antibody and complement treatments in null cell-type acute lymphocytic leukemia. Morishima Y; Sao H; Ueda R; Morishita Y; Murase T; Kodera Y; Ohno R; Tahara T; Yoshikawa S; Kato Y Jpn J Cancer Res; 1985 Dec; 76(12):1222-9. PubMed ID: 3937834 [TBL] [Abstract][Full Text] [Related]
5. Elimination of clonogenic tumor cells from human bone marrow using a combination of monoclonal antibody:ricin A chain conjugates. Bregni M; De Fabritiis P; Raso V; Greenberger J; Lipton J; Nadler L; Rothstein L; Ritz J; Bast RC Cancer Res; 1986 Mar; 46(3):1208-13. PubMed ID: 3510720 [TBL] [Abstract][Full Text] [Related]
6. Pharmacological bone marrow purging with drugs other than cyclophosphamide derivatives. Douay L Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():195. PubMed ID: 2469509 [No Abstract] [Full Text] [Related]
7. Serological study for in vitro use of monoclonal antibody for autologous bone marrow transplantation in null cell-type acute lymphocytic leukemia. Sao H; Morishima Y; Ueda R; Yoshikawa S; Kodera Y; Ohno R; Takahashi T Jpn J Cancer Res; 1985 Dec; 76(12):1212-21. PubMed ID: 3937833 [TBL] [Abstract][Full Text] [Related]
8. Autologous BMT in high risk patients with CALLA-positive ALL: possible efficacy of ex vivo marrow leukemia cell purging with monoclonal antibodies and complement. Morishima Y; Miyamura K; Kojima S; Ueda R; Morishita Y; Sao H; Tanimoto M; Ohno R; Sobue R; Hirano M Bone Marrow Transplant; 1993 Apr; 11(4):255-9. PubMed ID: 7683550 [TBL] [Abstract][Full Text] [Related]
9. Use of CD33 monoclonal antibodies in bone marrow transplantation for acute myeloid leukemia. Robertson MJ; Roy DC; Stone RM; Ritz J Prog Clin Biol Res; 1994; 389():47-63. PubMed ID: 7700916 [No Abstract] [Full Text] [Related]
10. [Ex vivo purging methods for autologous bone marrow transplantation]. Kojima S; Ueda R Nihon Rinsho; 1990 Sep; 48(9):2117-24. PubMed ID: 2232217 [No Abstract] [Full Text] [Related]
11. Continuous infusion of complement by an automated cell processor enhances cytotoxicity of monoclonal antibody sensitized leukemia cells. Howell AL; Fogg-Leach M; Davis BH; Ball ED Bone Marrow Transplant; 1989 May; 4(3):317-22. PubMed ID: 2659117 [TBL] [Abstract][Full Text] [Related]
12. Vim-2, candidate monoclonal antibody for purging autologous marrow grafts in acute myeloblastic leukaemia. Delwel R; Bot F; Knapp W; Löwenberg B Bone Marrow Transplant; 1987 Aug; 2(2):149-54. PubMed ID: 3332163 [TBL] [Abstract][Full Text] [Related]
13. Monoclonal antibodies and magnetic microspheres for the depletion of leukaemic cells from bone marrow harvested for autologous transplantation. Kemshead JT; Treleaven J; Heath L; Meara AO; Gee A; Ugelstad J Bone Marrow Transplant; 1987 Aug; 2(2):133-9. PubMed ID: 3332162 [TBL] [Abstract][Full Text] [Related]
14. Bone marrow purging with immunotoxins for treatment of T cell acute lymphoblastic leukemia (T-ALL). Vallera DA; Uckun FM Prog Clin Biol Res; 1990; 333():191-204; discussion 205. PubMed ID: 2308981 [No Abstract] [Full Text] [Related]
15. Bone-marrow purging with monoclonal antibodies and human complement in ALL and AML. Majdic O; Sugita K; Touw I; Köller U; Stockinger H; Delwel R; Löwenberg B; Knapp W Haematol Blood Transfus; 1987; 31():86-8. PubMed ID: 3327791 [No Abstract] [Full Text] [Related]
16. [Monoclonal antibody and purging]. Ueda R; Morishima Y Gan No Rinsho; 1989 May; Spec No():294-302. PubMed ID: 2601016 [No Abstract] [Full Text] [Related]
17. Removal of neoplastic cells from autologous bone marrow grafts with monoclonal antibodies. Jansen J; Falkenburg JH; Stepan DE; LeBien TW Semin Hematol; 1984 Jul; 21(3):164-81. PubMed ID: 6379879 [No Abstract] [Full Text] [Related]
18. Purging of bone marrow with a cocktail of monoclonal antibodies (VIB-pool) for autologous transplantation. Zintl F; Reiners B; Thränhardt H; Hermann J; Fuchs D; Prager J Haematol Blood Transfus; 1987; 31():89-91. PubMed ID: 3327792 [No Abstract] [Full Text] [Related]
19. Elimination of small cell lung cancer cells in vitro from human bone marrow by a monoclonal antibody. Okabe T; Kaizu T; Ozawa K; Urabe A; Takaku F Cancer Res; 1985 May; 45(5):1930-3. PubMed ID: 2985239 [TBL] [Abstract][Full Text] [Related]
20. Elimination of clonogenic breast cancer cells from human bone marrow. A comparison of immunotoxin treatment with chemoimmunoseparation using 4-hydroperoxycyclophosphamide, monoclonal antibodies, and magnetic microspheres. O'Briant KC; Shpall EJ; Houston LL; Peters WP; Bast RC Cancer; 1991 Sep; 68(6):1272-8. PubMed ID: 1873781 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]